Beam Therapeutics Inc.

BEAM· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$25.84-5.09%

2026-11-02

Financials

Valuation Metrics

Beam Therapeutics Inc.'s Market Cap is $2.66B. At end of 2025 it was $2.85B. Ranked #1728 of 3,116 in US market (top 55%), #618 of 1,472 on NASDAQ (top 42%), #107 of 265 in Pharmaceuticals, Biotechnology & Life Sciences (top 40%) by Market Cap.

Investment Metrics(as of 2026-11-02)

Metric	Value	Rank
Size
Market Cap	$2.66B	US#1,728/3,116 Sec#107/265
Revenue	$156M	US#2,594/3,116 Sec#115/265
Net Income	$-85M	US—/3,116 Sec—/265
Total Assets	$1.39B	US#2,297/3,116 Sec#73/265
Net Assets	$1.07B	US#1,711/3,116 Sec#59/265
Value
P/B	2.49x	US#1,667/3,116 Sec#89/265
P/S	17.04x	US#2,836/3,116 Sec#140/265
FCF Yield	-9.10%	US—/3,116 Sec—/265
Profitability
ROE	-8.00%	US#2,320/3,116 Sec#78/265
ROA	-6.16%	US#2,568/3,116 Sec#92/265
Op. Margin	-242.27%	US#2,753/3,116 Sec#139/265
Revenue Growth	158.88%	US#64/3,116 Sec#23/265
Financial Health
Debt Ratio	29.90%	US#335/3,116 Sec#104/265
Total Debt	$247M	US#2,166/3,116 Sec#90/265
FCF	$-242M	US#2,817/3,116 Sec#225/265
Cash	$220M	US#1,655/3,116 Sec#101/265
Current Ratio	14.57x	US#169/3,116 Sec#51/265
Performance
1Y Return	3.34%	US#1,292/3,116 Sec#117/265
1M Return	5.49%	US#300/3,116 Sec#25/265
From 52W High	-32.45%	US#1,765/3,116 Sec#109/265
1Y MDD	-39.08%	US#1,892/3,116 Sec#116/265
Trading
Volume	1,121,511 shares	US#924/3,116 Sec#89/265
Trading Value	$30M	US#1,216/3,116 Sec#80/265
Per Share
EPS	$-0.83	US—/3,116 Sec—/265
BPS	$10.38	US#1,812/3,116 Sec#68/265